Company ProfilePremium

Aekyung Petrochemical Co., Ltd.

Company Profile Analysis

Ticker: 161000.KS애경케미칼 주식회사

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aekyung Petrochemical Co., Ltd. - Company showcase

Year Founded & Workforce

1970

747 Employees

Aekyung Petrochemical Co., Ltd. logo

Aekyung Petrochemical Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aekyung Petrochemical Co., Ltd. Overview

Aekyung Chemical is the chemicals arm of Korea's Aekyung Group and the country's largest producer of phthalic anhydride and plasticizers by capacity. The 2021 three-way merger added unsaturated polyester and coating resins, surfactants and a biodiesel/bio-heavy-oil business, giving four operating segments. The legacy portfolio is commodity-like and has been squeezed by Chinese capacity additions: consolidated revenue fell from KRW 2.18 trillion in 2022 to KRW 1.45 trillion in 2025, when the company posted an operating loss. Management's response is a pivot to specialty materials: Korea's first domestic terephthaloyl chloride (TPC) plant for aramid fibre (15,000 t/y, Ulsan), hard-carbon anode material for sodium-ion batteries (Jeonju), and an Indonesian surfactant plant bought from Evonik. First-half 2026 results show a sharp recovery from a very low base. The investment case rests on whether these new lines reach commercial scale.


Company description. DART-derived profiles describe the company as having absorbed Aekyung Chemical (old) and AK ChemTech to expand into four strategic operating segments (plasticizers, synthetic resins, household chemicals, and bio & energy) with a focus on environmentally friendly products. Main products named are phthalic anhydride, coating resins, surfactants and biodiesel. WiseReport notes eleven consolidated subsidiaries.

Independent characterization. This is a mid-cap, product-sales chemical manufacturer. Revenue is essentially 100% product sales; there is no subscription or licensing revenue of note (licensing income: not publicly disclosed). The company sits mid-stream: it buys petrochemical feedstocks (ortho-xylene, alcohols, styrene monomer, glycols, vegetable oils and waste oils) and sells intermediates and formulated chemicals to industrial customers. Margins are spread-driven and cyclical.

Value chain and customers.

Geographically, the company operates in South Korea, Vietnam and China (Simply Wall St), with Indonesia added in October 2025.

Strategy

Strategic themes from management statements and press (2025–2026): shift from commodity to specialty; localisation of imported advanced materials; next-generation battery materials; overseas production bases; eco-friendly products at 50% of the portfolio by 2030.

Timeline slippage is material: TPC mass production was first guided for January 2026, then March 2026, then first-half 2026, and is now October 2026. Formal numeric guidance for 2026: not publicly disclosed.

Products & Services

Pricing is spot and contract, negotiated; no list pricing is disclosed. Launch years are not disclosed except where stated.

Plasticizers segment

Synthetic Resins segment

Household Chemicals segment

Bio & Energy segment

Product list drawn from the Simply Wall St company description and Korean press; grade-level specifications are not publicly disclosed in the sources reviewed.

Product Portfolio

ProductDescriptionTarget customer

Phthalic anhydride (PA)

Core intermediate from ortho-xylene; feedstock for plasticizers, resins, pigments; company is Korea's largest by capacity

Plasticizer, resin and pigment makers

General-purpose plasticizers

Phthalate types (DOP, DINP class)

PVC flooring, wallcovering, film, cable

Functional and eco-friendly plasticizers

Non-phthalate types (DOTP class and specialty grades)

Medical, toys, food-contact, automotive

Maleic anhydride

Intermediate for unsaturated polyester resins

Resin makers

Itaconic acid

Specialty acid monomer

Polymer and additive makers

Lubricant base oils

Synthetic ester base stocks

Lubricant blenders

TPC (terephthaloyl chloride)

—

Aramid fibre producers

ProductDescriptionTarget customer

Unsaturated polyester resins

Resins for composite materials

FRP moulders: marine, tanks, construction

Coating resins

Resins for paints

Paint manufacturers

Adhesives

Industrial adhesive resins

Packaging, lamination

Polyisocyanate hardener

Isocyanate curing agent

Coatings, polyurethane

Polyester polyol

Aromatic-structure polyol for urethane systems

Insulation and foam makers

ProductDescriptionTarget customer

Surfactants

Anionic and non-ionic surfactants; Korean, Vietnamese and (from October 2025) Indonesian production

Detergent and personal care formulators

ProductDescriptionTarget customer

Biodiesel

Blending component under Korea's renewable fuel standard

Refiners

Bio-heavy oil

Power-generation fuel; demand tied to the Renewable Portfolio Standard

Power generators

Hard carbon anode material (AHC-3 series)

Biomass-based anode material for sodium-ion batteries; pilot output and customer evaluation under way

Battery makers

Financial Narrative

Consolidated, K-IFRS.

Income statement

Margins

Notes: FY2022 margins are calculated. The vendor series (valueinvesting.io) appears to use net income attributable to controlling shareholders, which explains the FY2024–FY2025 differences. Preliminary press reports put the FY2025 operating loss at KRW 10.1 billion; the company IR page shows KRW 10.2 billion. Revenue CAGR FY2022–FY2025: -12.6% (calculated).

Balance sheet

Dividends implied at about KRW 6.8 billion for FY2025 (140 x 48.28M shares, calculated).

Ratios

Asset turnover is calculated on year-end assets.

Interim results

The H1 2026 absolute values are derived by applying the reported growth rates to rounded H1 2025 figures and are sensitive to rounding; confirm against the half-year report.

Commentary. Revenue has fallen three years running, a cumulative KRW 724 billion, or one third, from the 2022 peak. The driver is the plasticizer chain, where Chinese capacity additions compressed prices and displaced domestic volume. Operating profit moved from KRW 95.1 billion to a KRW 10.2 billion loss, and EBITDA fell by two thirds. The balance sheet moved the other way: total assets grew each year while equity shrank in 2025, so liabilities to equity rose 17 points in two years, consistent with debt-funded capex on the TPC plant and the Indonesian acquisition during an earnings trough. The parent-only accounts stayed marginally profitable in 2025 (operating profit KRW 1.3 billion, net income KRW 2.2 billion), which locates the 2025 loss in the consolidated subsidiaries. The FY2024 dividend of KRW 281 per share exceeded earnings more than threefold; the FY2025 cut to KRW 140 was still paid out of a loss, underlining the parent holding company's reliance on upstream dividends. First-half 2026 marks the inflection, helped by bio-heavy-oil demand and a low base.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment revenue

Segment revenueFY2022FY2023FY2024

Plasticizers (KRW 100M)

10,147—7,813

Bio & Energy (KRW 100M)

3,760—2,640

Consolidated total (KRW 100M)

21,76417,93716,422

Share of consolidated revenue

Share of consolidated revenueFY2022FY2024

Plasticizers (%)

46.647.6

Bio & Energy (%)

17.316.1

Income Statement (KRW) and Per-Share Data

MetricFY2022FY2023FY2024FY2025

Revenue (KRW 100M)

21,76417,93716,42214,523

Operating income (KRW 100M)

951451155-102

EBITDA (KRW 100M)

1,280—530419

Net income (KRW 100M)

59433085-49

EPS basic (KRW)

———-61

Dividend per share (KRW)

—250281140

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Operating margin (%)

—4.372.510.94-0.70

EBITDA margin (%)

—5.88—3.232.89

Net margin, company basis (%)

—2.731.840.52-0.34

Net margin, vendor basis (%)

4.932.761.850.24-0.20

Balance Sheet (KRW)

MetricFY2023FY2024FY2025

Total assets (KRW 100M)

13,08413,56413,943

Total liabilities (KRW 100M)

5,7206,1556,779

Total equity (KRW 100M)

7,3637,4107,164

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2023FY2024FY2025

ROE (%)

4.520.54-0.41

ROA (%)

2.590.64-0.36

Liabilities to equity (%)

77.6983.0794.63

Asset turnover (x)

1.371.211.04

Dividend payout (%)

36.46340.74-229.21

Dividend yield (%)

1.634.111.47

Revenue History

PeriodRevenue (KRW 100M)Operating income (KRW 100M)Net income (KRW 100M)Source

H1 2025

7,46227—

Dealsite

Q4 2025

3,484—-106

GoInsider (amended filing)

Q1 2026

3,70658-14

DART-derived aggregator

H1 2026

about 8740 (derived)

about 495 (derived)

Positive

WiseReport: revenue +17.1%, operating profit +1,732.8% YoY

Revenue by Region (KRW)

MetricFY2022FY2024

Plasticizer segment, domestic revenue (KRW 100M)

4,6921,935

Plasticizer segment, export and overseas revenue (KRW 100M, derived)

5,4555,878

Revenue by Region (KRW) (Half-Yearly)

MetricH1 2024H1 2025

Bio & Energy revenue (KRW 100M)

1,315842

Valuation Snapshot

MetricValueDate / source

Share price

KRW 10,260 (prior close)

WiseReport, September 2026

Share price

KRW 9,200

26 June 2026, Investing.com

Market capitalisation

About KRW 495 billion

Derived

P/E

Not meaningful (trailing loss; EPS KRW -61)

WiseReport

P/B

0.69 (BPS KRW 14,790)

WiseReport

EV/EBITDA

21.81 (FY2025)

WiseReport

EV/Sales

About 0.6 (derived from EV/EBITDA and EBITDA; approximate)

Calculated

Dividend yield

1.36%

WiseReport

Analyst coverage

Three or fewer brokers (LS Securities "low coverage" list, 2024); no consensus estimates

LS Securities; Simply Wall St

Dividend history

Dividend historyFY2023FY2024FY2025

Dividend per share (KRW)

250281140

Payout ratio (%)

36.46340.74-229.21

Analyst Conclusions

Guidance. No numeric guidance for 2026 was found. Management targets ROE above 8% by 2027 and positions 2026 as the year TPC and hard carbon begin to generate sales.

Bull case

  1. First-half 2026 operating profit of roughly KRW 49–50 billion (derived) already exceeds full-year 2023, showing operating leverage when spreads and bio-fuel demand recover.

  2. TPC adds a higher-margin, import-substituting product with a protected local position from October 2026.

  3. At 0.69 times book, the shares price in little value for hard carbon or Southeast Asian expansion.

Bear case

  1. The core plasticizer business faces structural, not cyclical, Chinese oversupply; domestic segment sales fell 59% in two years.

  2. Leverage rose through the trough, and the parent holding company's need for dividends competes with capex.

  3. New businesses have slipped repeatedly and have no disclosed offtake contracts; the FTC probe is unresolved.

Catalysts and monitorables (next 12 months). Q3 2026 report by 16 November 2026; TPC utilisation and first disclosed supply volumes; completion of the 1,300 t/y hard carbon line and customer qualification; FTC decision; FY2026 dividend; Indonesian plant contribution; any AK Holdings restructuring.

Analyst verdict. Aekyung Chemical is a commodity intermediates business in the middle of an attempted conversion to specialty materials, and the evidence so far supports the diagnosis more than the cure. The diagnosis is clear in the numbers: a third of revenue lost since 2022, EBITDA down by two thirds, and a first consolidated operating loss in 2025, all traceable to Chinese plasticizer capacity that is unlikely to retreat. The cure consists of three projects. TPC is the most credible: the plant is built, the company is the only domestic supplier, and Korean aramid producers have a logistical reason to buy locally. Its weakness is a start-up timetable that moved four times in a year and the absence of any disclosed contract. Hard carbon is an option on sodium-ion adoption, with value only if pilot customers convert. Indonesia is sensible but small. Against this, the 2026 rebound is real but owes much to bio-heavy-oil demand and a depressed base, and the sustainability of that segment is clouded by an antitrust investigation. The balance sheet remains sound in absolute terms, yet leverage has risen while dividends were paid out of losses, a pattern that reflects the parent's needs more than the subsidiary's. On balance the shares look like a low-priced, thinly traded recovery situation with asymmetric dependence on one plant. The next two quarterly reports, which should show TPC revenue for the first time, will decide whether the specialty narrative deserves a multiple above book value. Until then, the appropriate stance is cautious and evidence-led.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleNotes

Pyo Kyung-won (표경원)

Chief Executive Officer

—

Seong-wan Kim

Listed as CEO by Simply Wall St

Conflicts with Korean sources; possibly a co-representative director or stale vendor data; unresolved

Chae Hyung-seok

Aekyung Group vice chairman; largest individual shareholder of AK Holdings (14.25% as of 2021)

Group-level controller, not confirmed as a director of the company

Competitive Landscape

Competitors by Segment

SegmentNamed competitors

Phthalic anhydride and plasticizers

LG Chem, Hanwha Solutions, OCI, UPC Technology, Nan Ya Plastics, Bluesail, Eastman, BASF, Evonik

Synthetic resins

Kukdo Chemical, KCC, Polynt, AOC

Surfactants

Miwon Commercial, LG Household & Health Care (captive), Kao, Stepan

Biodiesel and bio-heavy oil

SK Eco Prime, GS Bio, Dansuk Industrial, JC Chemical

TPC

Chinese and Japanese import suppliers (previously 100% of Korean supply)

Hard carbon

Kuraray, BTR, other Chinese anode makers

Company Snapshot

747

Employees

1970

Founded

SWOT Analysis

Strengths

  • Domestic capacity leadership in PA and plasticizers (CEO Score Daily, 2021).
  • Four-segment portfolio after the 2021 merger, spreading exposure across PVC, composites, detergents and energy.
  • First and only Korean TPC plant, 15,000 t/y.
  • In-house process development proven through pilot and demo plants for TPC.
  • Positive equity of KRW 716.4 billion and reserve ratio above 2,800% (FY2025).
  • Parent-only accounts remained profitable in FY2025 (net income KRW 2.2 billion).

Weaknesses

  • Revenue down 33% from FY2022 to FY2025.
  • FY2025 consolidated operating loss of KRW 10.2 billion.
  • EBITDA down from KRW 128 billion (2022) to KRW 41.9 billion (2025).
  • Liabilities to equity up from 77.7% to 94.6% in two years.
  • Dividends paid in excess of earnings in FY2024 (payout 341%) and from a loss in FY2025.
  • Repeated slippage in the TPC start-up timetable (January to October 2026).

Opportunities

  • Import substitution in TPC, a higher-margin product than the legacy range.
  • Hard carbon scale-up from 1,300 t/y toward 20,000 t/y if customers qualify the material.
  • Indonesian and Vietnamese production for regional surfactant and plasticizer demand.
  • Bio-heavy-oil demand under the Renewable Portfolio Standard, already lifting 2026 results.
  • Non-phthalate plasticizer demand from tightening regulation; 50% eco-friendly target by 2030.
  • Valuation re-rating potential from a price-to-book ratio of 0.69.

Threats

  • Continued Chinese plasticizer oversupply.
  • FTC biodiesel cartel investigation, with possible fines.
  • Customer concentration in TPC among a handful of aramid producers; aramid oversupply would feed back.
  • Sodium-ion commercialisation risk; hard carbon revenue remains unproven.
  • Group risk: Jeju Air accident aftermath and AK Holdings' reliance on subsidiary dividends.
  • Industry-wide restructuring of Korean petrochemicals amid prolonged global oversupply (Samjong KPMG 2026 outlook).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
H1 2025Revenue KRW 746.2 billion (-13% YoY), operating profit KRW 2.7 billion (-77%)Trough conditions
H1 2025Bio & Energy exports fall to zeroSegment weakness
2025AK Holdings sells Aekyung Industrial to TaekwangCompany becomes a larger share of group value
Sep 2025Dealsite reports FTC investigation into biodiesel price collusionLegal and ESG overhang
31 Oct 2025Evonik Indonesian surfactant plant acquisition closesFirst Indonesian base
Q4 2025Revenue KRW 348.4 billion; net loss KRW 10.6 billionLoss-making quarter
End 2025TPC plant mechanical completionStart of commissioning
11 Feb 2026Group release: TPC completion in March; hard carbon 1,300 t/y expansion; 20,000 t/y ambitionRoadmap restated
13–16 Mar 2026FY2025 results: revenue KRW 1,452.3 billion; operating loss KRW 10.2 billion; net loss KRW 4.9 billionFirst annual operating loss post-merger
Mar 2026Amended business report correcting Q4 figuresDisclosure quality point
Mar 2026DPS cut to KRW 140 from KRW 281Payout halved
Apr 2026NH Investment & Securities analyst comment: plasticizer stagnation; TPC is the key earnings driverSell-side framing
15 May 2026Q1 2026: revenue KRW 370.6 billion (+0.2%), operating profit KRW 5.8 billion, net loss KRW 1.4 billionReturn to operating profit
Aug 2026H1 2026: revenue +17.1%, operating profit +1,732.8%, net profit positiveRecovery confirmed
22 Sep 2026TPC full production set for October; hard carbon expansion by year-endFurther delay versus earlier guidance
16 Nov 2026Statutory deadline for Q3 2026 reportNext catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (KRW): Plasticizers fell from KRW 10,147 in FY2022 to KRW 7,813 in FY2024.
Aekyung Petrochemical Co., Ltd. — Revenue by Segment (KRW)
Series (KRW)FY2022FY2023FY2024
Plasticizers10,147—7,813
Bio & Energy3,760—2,640
Consolidated total21,76417,93716,422

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.